| Mitoxantrone studied in …STUDIED_INderived200 of 217show all (up to 200) |
|---|
| → studied in | NCT03182244Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293562Phase 3 · recruiting A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521493Phase 3 · active not recruiting Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia Associated with Down Syndrome,Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07131059NA · recruiting MRD-positive AML Clinical Study · 217 trials list this drug (18 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101853Phase 3 · active not recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591510Phase 2 · active not recruiting A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724163Phase 3 · active not recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195945Phase 2 · completed CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02553460Phase 1/Phase 2 · active not recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983824Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371981Phase 3 · completed Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Myeloid Sarcoma,Leukemia Cutis+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02583893Phase 2 · completed Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · 217 trials list this drug (18 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632708Phase 1 · active not recruiting Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164057Phase 2 · active not recruiting A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04797767Phase 1/Phase 2 · recruiting Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Myeloid Sarcoma,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250338Phase 3 · completed Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339740Phase 3 · active not recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia · 217 trials list this drug (18 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523976Phase 2 · completed Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03926624Phase 3 · terminated Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07354698Phase 4 · not yet recruiting Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery · 217 trials list this drug (18 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06429449Phase 1 · recruiting Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia,Myeloid Leukemia,Acute Monocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03118466Phase 2 · completed Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860844Phase 2 · terminated Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06262438Phase 2 · recruiting CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303821Phase 1 · completed Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01184898NA · completed Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04778410Phase 2 · terminated Study of Magrolimab Combinations in Participants With Myeloid Malignancies · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441048Phase 1 · completed Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484391Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma · 217 trials list this drug (18 active) | — | — | Granulocytic Sarcoma,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06007911Phase 1 · withdrawn Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02400281Phase 1/Phase 2 · completed Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04196010Phase 1 · terminated Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626338Phase 1/Phase 2 · completed Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520011Phase 2 · terminated Alvocidib Biomarker-driven Phase 2 AML Study · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004197Phase 2 · completed Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03531918Phase 1/Phase 2 · completed Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05313958Phase 2/Phase 3 · unknown Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children · 217 trials list this drug (18 active) | — | — | Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728050Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005847Phase 2 · completed Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299518Phase 1 · completed Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05330377Phase 1 · withdrawn GM-CLAG in Relapsed/Refractory FLT3-mutated AML · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199069Phase 4 · completed German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) · 217 trials list this drug (18 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00744081Phase 2 · completed Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML) · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003407Phase 2 · withdrawn Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004124Phase 3 · completed S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154439Phase 1 · completed Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842672Phase 1/Phase 2 · completed Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Burkitt Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01700946Phase 2 · completed Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma · 217 trials list this drug (18 active) | — | — | Childhood B Acute Lymphoblastic Leukemia,Childhood B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200978Phase 4 · completed A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia · 217 trials list this drug (18 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290511Phase 2 · completed Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563560Phase 1 · completed A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03012672Phase 2 · completed Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193479Phase 2 · completed Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756572Phase 2 · completed Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms · 217 trials list this drug (18 active) | — | — | Myeloid Neoplasm,High Grade Malignant Neoplasm,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003405Phase 2 · withdrawn Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00372593Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003650Phase 3 · completed Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304291Phase 4 · completed A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577993Phase 3 · completed Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483690Phase 1/Phase 2 · terminated A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01830777Phase 1 · completed Brentuximab Vedotin + Re-induction Chemotherapy for AML · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02573363Phase 1 · completed Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00853008Phase 4 · completed Treatment of High Risk Adult Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003232Phase 3 · completed Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00901927Phase 2 · terminated Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma · 217 trials list this drug (18 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003032Phase 3 · completed High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921061Phase 1/Phase 2 · completed Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044796Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,De Novo Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015951Phase 2 · completed Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204710Phase 2 · completed A Study of Olaratumab (IMC-3G3) in Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00169208Phase 2 · completed Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535806Phase 2 · terminated Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550992NA · unknown Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882076Phase 1 · terminated Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024241unknown Medium Dose of Cytarabine and Mitoxantrone · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03735446Phase 1 · terminated Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306291Phase 1/Phase 2 · completed Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254410Phase 2 · completed FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years · 217 trials list this drug (18 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518750Phase 2 · terminated Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma · 217 trials list this drug (18 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458848Phase 2 · completed Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729845Phase 1/Phase 2 · completed Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02070458Phase 1 · completed Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002835Phase 3 · completed Combination Chemotherapy in Treating Patients With Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059631Phase 1 · completed Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002565Phase 3 · completed Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01768897Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q),Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522443Phase 3 · terminated Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer · 217 trials list this drug (18 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274963Phase 2 · completed Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia · 217 trials list this drug (18 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278213Phase 2 · completed Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · 217 trials list this drug (18 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Erythroid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003003Phase 1 · completed Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02419755Phase 2 · terminated Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02198482Phase 2 · terminated Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631252Phase 1 · terminated Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268242Phase 2 · terminated Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562965Phase 3 · terminated Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) · 217 trials list this drug (18 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00609739Phase 1/Phase 2 · terminated Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005985Phase 2 · completed Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005987Phase 2 · terminated Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005998Phase 2 · withdrawn Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477087Phase 2 · terminated Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer · 217 trials list this drug (18 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331344Phase 1/Phase 2 · completed Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy · 217 trials list this drug (18 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249430Phase 1 · completed Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01594918Phase 1 · completed Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer · 217 trials list this drug (18 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00182741Phase 2 · completed Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017563Phase 2 · completed Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151255Phase 3 · completed All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00906945Phase 1/Phase 2 · completed Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079105Phase 2 · completed A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058084Phase 2 · completed Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512252Phase 1/Phase 2 · completed AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661492Phase 2 · completed Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) · 217 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00656084Phase 2 · completed Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell · 217 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01144403Phase 2 · terminated A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma. · 217 trials list this drug (18 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416910Phase 3 · terminated Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia · 217 trials list this drug (18 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02848183Phase 2 · unknown Optimal Treatment Strategy Based on for Pediatric AML · 217 trials list this drug (18 active) | — | — | Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003858Phase 2 · withdrawn Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174888Phase 1 · completed Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00546377Phase 1/Phase 2 · completed Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer · 217 trials list this drug (18 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00447473Phase 2 · terminated Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer · 217 trials list this drug (18 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01681537Phase 1 · completed Lenalidomide Plus Chemotherapy for AML · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002766Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma · 217 trials list this drug (18 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124566Phase 2 · completed Study of Irofulven in Patients With Hormone-refractory Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660036Phase 1 · terminated Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00317408NA · unknown Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403415Phase 1 · completed Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma · 217 trials list this drug (18 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004497Phase 2 · completed First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL · 217 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00109837Phase 2 · completed S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027923Phase 1 · terminated IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408278Phase 4 · completed Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) · 217 trials list this drug (18 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00683475Phase 2 · completed A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385827Phase 2 · terminated A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002805Phase 2 · completed Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510887Phase 2 · terminated Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma · 217 trials list this drug (18 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119730Phase 2 · completed Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma · 217 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00770848Phase 1/Phase 2 · completed AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004001Phase 3 · completed S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028899Phase 1 · completed Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070174Phase 2 · completed Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00774046Phase 2 · completed High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML · 217 trials list this drug (18 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02043756Phase 1 · completed Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection · 217 trials list this drug (18 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002658Phase 3 · unknown Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002688Phase 2 · unknown Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003633Phase 1 · unknown Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003893Phase 3 · completed Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002498Phase 2 · unknown Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005823Phase 3 · completed Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003183Phase 1/Phase 2 · unknown Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003436Phase 3 · completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004237Phase 2 · completed Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006045Phase 3 · unknown Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016016Phase 1/Phase 2 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia · 217 trials list this drug (18 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Lymphoblastic Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470197Phase 1 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia · 217 trials list this drug (18 active) | — | — | Malignant Neoplasm,Adult Acute Lymphoblastic Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002701Phase 3 · unknown Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002905Phase 2 · unknown Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003602Phase 3 · unknown Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006250Phase 3 · unknown Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00032149Phase 1/Phase 2 · unknown Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002531Phase 2 · unknown Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967057Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002576Phase 3 · completed Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002544Phase 3 · completed Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00337246Phase 2 · completed Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00842595Phase 2 · completed Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas · 217 trials list this drug (18 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005867Phase 3 · completed Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002598Phase 2 · completed Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002700Phase 3 · completed Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002474Phase 2 · completed Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer · 217 trials list this drug (18 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003957Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002819Phase 3 · terminated Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer · 217 trials list this drug (18 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002912Phase 1 · completed Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003068Phase 2 · completed High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer · 217 trials list this drug (18 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004071Phase 2/Phase 3 · completed Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052299Phase 3 · completed Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003343Phase 3 · completed Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006122Phase 2 · completed Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436839Phase 3 · completed Taxotere Prostate Cancer New Indication Registration Trial in China · 217 trials list this drug (18 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002719Phase 3 · completed Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003215Phase 3 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma · 217 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00452387Phase 2 · terminated Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC) · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00180128Phase 4 · unknown AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00627354Phase 2 · completed Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy · 217 trials list this drug (18 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840684Phase 1/Phase 2 · completed Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003297Phase 1/Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer · 217 trials list this drug (18 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417079Phase 3 · completed XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer · 217 trials list this drug (18 active) | — | — | Neoplasm,Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053131Phase 2 · completed Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · 217 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |